CORDIS · 263307 · FP7
SAVEME A Modular Nanosystems Platform for Advanced Cancer Management: Nano-vehicles; Tumor Targeting and Penetration Agents; Molecular Imaging, Degradome based Therapy
Coordinator: TEL AVIV UNIVERSITY (IL)
SaveMe project will address current urgent needs for pancreatic cancer diagnosis and treatment by exploiting partners’ expertise and most recent research achievements for the design and development of novel modular nanosystems platform integrating new functionalized nano-core particles and active agents. The modular platform will enable the design of diverse active nanosystems per diagnostic or therapeutic application as defined by their active agent compositions. For diagnostics, superior tracers will be developed for molecular MR/PET and gamma camera imaging, enabling efficient diagnosis an…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €10.5M awarded to the consortium. The project runs over approximately 4 years from 2011-03-01 to 2015-02-28.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from IL
see all →- CloudCT — Climate CT- Cloud Tomography by Satellites for Better Climate Prediction810370 · H2020 · €13.9M
- LUCIA — Understanding Lung Cancer related risk factors and their Impact101096473 · HORIZON · €13.5M
- D2Smell — Digitising Smell: From Natural Statistics of Olfactory Perceptual Space to Digital Transmission of Odors101118977 · HORIZON · €11.8M
- SIIP — Speaker Identification Integrated Project607784 · FP7 · €10.5M
- CATO — CATO - CBRN crisis management: Architecture, Technologies and Operational Procedures261693 · FP7 · €10.3M
- UnMySt — Unraveling the Mysteries of Vibrational Strong Coupling101167294 · HORIZON · €10.0M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-IP funding scheme.
- What is the EU contribution?
- The European Commission contributes €10.5M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by TEL AVIV UNIVERSITY (IL).
- What is the project timeline?
- The project runs from 2011-03-01 to 2015-02-28 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 263307.